Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
FDA to pull common but ineffective cold medicine from market
The
FDA
's proposal comes more than a year after the agency's outside advisers voted against continued use of the ingredient, called oral
phenylephrine
, citing concerns with the initial data used to support its approval and new data questioning its ...
After decades, FDA finally moves to pull ineffective decongestant off shelves
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a common over-the-counter decongestant, which the agency concluded last year is not effective at relieving stuffy noses.
FDA proposes removing ineffective decongestant found in most cold medicine
The move brings
FDA
one step closer to getting products containing oral
phenylephrine
pulled from stores.
FDA
officials said an agency review of the available data found oral
phenylephrine
is not effective as a nasal decongestant when taken in liquid or ...
FDA proposes ending use of popular decongestant present in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
FDA wants to remove popular decongestants from stores permanently that contain this ingredient
ATLANTA — The Food and Drug Administration says it wants to remove some of the most popular over-the-counter decongestants that have a common ingredient in them. The FDA said there’s evidence that phenylephrine doesn’t work. Brand names like Sudafed, DayQuil and others contain the ingredient.
FDA proposes removing popular decongestant found in cold meds
The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy medications – oral phenylephrine.
FDA Recommends Removing Ingredient From Many Cold and Allergy Medicines After Research Shows It Doesn't Work
Cold and flu season is upon us and Americans will be flocking to pharmacy shelves to pick up some medicine to alleviate their symptoms. But the ingredients list on many of these products might start to look very different based on new guidance from the Food and Drug Administration.
FDA looks to remove ineffective decongestant
The Food and Drug Administration (FDA) is proposing the removal of a common ingredient, oral phenylephrine, found in most over-the-counter cold medicines for being ineffective as a nasal decongestant in liquid or pill form.
FDA says commonly used decongestant 'not effective,' proposes removal
The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants.
NBC News on MSN
16h
FDA proposes ending use of decongestant found in many cold, allergy medicines
The agency said an extensive review of available data determined that the ingredient, oral
phenylephrine
, doesn’t actually ...
HealthDay on MSN
10h
FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, ...
19h
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph Nasal Decongestant Active Ingredient After Extensive Review
Today, the U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph drug products for the ...
6d
Litigators of the Week: An Early Knockout Win in the Decongestant MDL
After Andrew Soukup of Covington & Burling and Jay Lefkowitz of Kirkland & Ellis argued the motion to dismiss for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
popular decongestant
Food and Drug Administration
Feedback